{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:15:22Z","timestamp":1758759322479,"version":"3.44.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,24]]},"DOI":"10.7759\/cureus.93114","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T14:25:56Z","timestamp":1758723956000},"source":"Crossref","is-referenced-by-count":0,"title":["Bullous Systemic Lupus Erythematosus As the Initial Presentation of Systemic Lupus Erythematosus"],"prefix":"10.7759","author":[{"given":"Cholponai","family":"Kydyralieva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12355210","article-title":"Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder","volume":"100","author":"Gammon WR","year":"1993","unstructured":"Gammon WR, Briggaman RA. Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol. 1993, 100:28S-34S. 10.1111\/1523-1747.ep12355210","journal-title":"J Invest Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06557.x","article-title":"Diagnostic approach and treatment of cutaneous lupus erythematosus","volume":"6","author":"Sticherling M","year":"2008","unstructured":"Sticherling M, Bonsmann G, Kuhn A. Diagnostic approach and treatment of cutaneous lupus erythematosus. J Dtsch Dermatol Ges. 2008, 6:48-59. 10.1111\/j.1610-0387.2007.06557.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7162\/S1809-977720130003000016","article-title":"Bullous systemic lupus erythematosus: case report","volume":"17","author":"Miziara ID","year":"2013","unstructured":"Miziara ID, Mahmoud A, Chagury AA, Alves RD. Bullous systemic lupus erythematosus: case report. Int Arch Otorhinolaryngol. 2013, 17:344-6. 10.7162\/S1809-977720130003000016","journal-title":"Int Arch Otorhinolaryngol"},{"key":"ref4","article-title":"Bullous systemic lupus erythematosus","author":"Odonwodo A","year":"2025","unstructured":"Odonwodo A, Vashisht P. Bullous systemic lupus erythematosus. StatPearls Publishing. StatPearls, Treasure Island, FL; 2025."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.047","article-title":"Diagnosis and classification of autoimmune blistering diseases","volume":"13","author":"Baum S","year":"2014","unstructured":"Baum S, Sakka N, Artsi O, Trau H, Barzilai A. Diagnosis and classification of autoimmune blistering diseases. Autoimmun Rev. 2014, 13:482-9. 10.1016\/j.autrev.2014.01.047","journal-title":"Autoimmun Rev"},{"key":"ref6","unstructured":"Bullous Systemic Lupus Erythematosus (BSLE) Clinical Presentation. (2025). Accessed. August 25, 2025: https:\/\/emedicine.medscape.com\/article\/1065402-clinical?utm_source=chatgpt.com&form=fpf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.04.249","article-title":"Bullous systemic lupus erythematosus presenting initially as a vesiculobullous eruption without overt manifestations of SLE","volume":"76","year":"2017","unstructured":"Bullous systemic lupus erythematosus presenting initially as a vesiculobullous eruption without overt manifestations of SLE. J Am Acad Dermatol. 2017, 76.6. 10.1016\/j.jaad.2017.04.249","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000034","article-title":"Bullous systemic lupus erythematosus in females","volume":"8","author":"Sprow G","year":"2022","unstructured":"Sprow G, Afarideh M, Dan J, Hedberg ML, Werth VP. Bullous systemic lupus erythematosus in females. Int J Womens Dermatol. 2022, 8:e034. 10.1097\/JW9.0000000000000034","journal-title":"Int J Womens Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.05.017","article-title":"Autoimmune blistering diseases of the skin","volume":"11","author":"Sticherling M","year":"2012","unstructured":"Sticherling M, Erfurt-Berge C. Autoimmune blistering diseases of the skin. Autoimmun Rev. 2012, 11:226-30. 10.1016\/j.autrev.2011.05.017","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/167064","article-title":"Treatment of bullous systemic lupus erythematosus","volume":"2015","author":"Duan L","year":"2015","unstructured":"Duan L, Chen L, Zhong S, et al.. Treatment of bullous systemic lupus erythematosus. J Immunol Res. 2015, 2015:167064. 10.1155\/2015\/167064","journal-title":"J Immunol Res"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)09600-4","article-title":"Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone","volume":"273","author":"Grossman S","year":"1995","unstructured":"Grossman S, Budinsky R, Jollow D. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone. J Pharmacol Exp Ther. 1995, 273:870-7.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(09)80273-9","article-title":"Dapsone-associated agranulocytosis and severe anemia in a patient with leukocytoclastic vasculitis","volume":"28","author":"Woodbury Jr GR","year":"1993","unstructured":"Woodbury Jr GR, Fried W, Ertle JO, Malkinson FD. Dapsone-associated agranulocytosis and severe anemia in a patient with leukocytoclastic vasculitis. J Am Acad Dermatol. 1993, 28:781-3. 10.1016\/s0190-9622(09)80273-9","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S403866","article-title":"Refractory bullous systemic lupus erythematosus successfully treated with rituximab: a case report and literature review","volume":"16","author":"Ratanapokasatit Y","year":"2023","unstructured":"Ratanapokasatit Y, Seree-Aphinan C, Chanprapaph K. Refractory bullous systemic lupus erythematosus successfully treated with rituximab: a case report and literature review. Clin Cosmet Investig Dermatol. 2023, 16:883-90. 10.2147\/CCID.S403866","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202211_30151","article-title":"First case presentation of refractory pediatric bullous lupus erythematosus (BSLE) treatment with belimumab","volume":"26","author":"Zeng HQ","year":"2022","unstructured":"Zeng HQ, Lu XP, Yan ZB, Ye ZZ. First case presentation of refractory pediatric bullous lupus erythematosus (BSLE) treatment with belimumab. Eur Rev Med Pharmacol Sci. 2022, 26:7980-5. 10.26355\/eurrev_202211_30151","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/413843-bullous-systemic-lupus-erythematosus-as-the-initial-presentation-of-systemic-lupus-erythematosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T14:25:58Z","timestamp":1758723958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/413843-bullous-systemic-lupus-erythematosus-as-the-initial-presentation-of-systemic-lupus-erythematosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.93114","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,24]]}}}